Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Cardiovascular Research

• Publication date

  2002-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0008-6363(02)00541-2PMID 12393095
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for calcineurin-mediated regulation of SERCA 2a activity in human myocardium.

  2002cited by this paper
• Targeting Phospholamban by Gene Transfer in Human Heart Failure

  2002cited by this paper
• Interactions Between Phospholamban and &bgr;-Adrenergic Drive May Lead to Cardiomyopathy and Early Mortality

  2001cited by this paper
• Radiofrequency ablation of a posteroseptal accessory pathway associated with two diverticula of the coronary sinus.

  2001cited by this paper
• Phospholamban domain IB forms an interaction site with the loop between transmembrane helices M6 and M7 of sarco(endo)plasmic reticulum Ca2+ ATPases

  2001cited by this paper
• The Transgenic Expression of Highly Inhibitory Monomeric Forms of Phospholamban in Mouse Heart Impairs Cardiac Contractility*

  2000cited by this paper
• Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects.

  2000cited by this paper
• Frequency-encoding Thr17 Phospholamban Phosphorylation Is Independent of Ser16 Phosphorylation in Cardiac Myocytes*

  2000cited by this paper
• Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase.

  2000cited by this paper
• Cardiac-specific Overexpression of a Superinhibitory Pentameric Phospholamban Mutant Enhances Inhibition of Cardiac Functionin Vivo *

  2000cited by this paper
• PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

  2000cited by this paper
• Reexamination of the Role of the Leucine/Isoleucine Zipper Residues of Phospholamban in Inhibition of the Ca2+ Pump of Cardiac Sarcoplasmic Reticulum*

  2000cited by this paper
• Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.

  1999cited by this paper
• Modulation of force-frequency relation by phospholamban in genetically engineered mice.

  1999cited by this paper
• Origin of contractile dysfunction in heart failure: calcium cycling versus myofilaments.

  1999cited by this paper
• Impaired force-frequency relations in patients with hypertensive left ventricular hypertrophy. A possible physiological marker of the transition from physiological to pathological hypertrophy.

  1999cited by this paper
• Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a.

  1999cited by this paper
• Desmin mutation responsible for idiopathic dilated cardiomyopathy.

  1999cited by this paper
• Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium.

  1999cited by this paper
• Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation.

  1999cited by this paper
• Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer.

  1999cited by this paper
• Reduced Ca2+-Sensitivity of SERCA 2a in Failing Human Myocardium due to Reduced Serin-16 Phospholamban Phoshorylation

  1999cited by this paper
• Transgenic Approaches to Define the Functional Role of Dual Site Phospholamban Phosphorylation*

  1998cited by this paper
• Molecular genetic studies of familial hypertrophic cardiomyopathy

  1998cited by this paper
• Phospholamban Domain Ib Mutations Influence Functional Interactions with the Ca2+-ATPase Isoform of Cardiac Sarcoplasmic Reticulum*

  1998cited by this paper
• Torsion angle dynamics for NMR structure calculation with the new program DYANA.

  1997cited by this paper
• Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure.

  1997cited by this paper
• Regulatory effects of phospholamban on cardiac function in intact mice.

  1997cited by this paper
• Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.

  1996cited by this paper
• A Leucine Zipper Stabilizes the Pentameric Membrane Domain of Phospholamban and Forms a Coiled-coil Pore Structure (*)

  1996cited by this paper
• In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency.

  1995cited by this paper
• Amino acids Glu2 to Ile18 in the cytoplasmic domain of phospholamban are essential for functional association with the Ca(2+)-ATPase of sarcoplasmic reticulum.

  1994cited by this paper
• Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.

  1994cited by this paper
• Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium.

  1994cited by this paper
• Intracellular Calcium Handling in Isolated Ventricular Myocytes From Patients With Terminal Heart Failure

  1992cited by this paper
• Diastolic dysfunction in congestive heart failure.

  1991cited by this paper
• Diastolic dysfunction in congestive heart failure.

  1991influential reference
• Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure.

  1990cited by this paper
• Relaxation and diastole of the heart.

  1989cited by this paper
• Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to beta-adrenergic stimulation.

  1989cited by this paper
• NMR of proteins and nucleic acids

  1988cited by this paper
• Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.

  1987cited by this paper

• Endoplasmic Reticulum Calcium Pumps and Tumor Cell Differentiation

  2020cites this paper
• Disease modelling of a phospholamban p.Arg14del mutation in hiPSC-derived cardiomyocytes

  2018cites this paper
• A novel human T17N-phospholamban variation in idiopathic dilated cardiomyopathy

  2018cites this paper
• Interactions between small ankyrin 1 and sarcolipin coordinately regulate activity of the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA1)

  2017cites this paper
• Calcium Uptake in Crude Tissue Preparation.

  2016cites this paper
• Genetic modifiers to the PLN L39X mutation in a patient with DCM and sustained ventricular tachycardia?

  2015cites this paper
• Identification of Small Ankyrin 1 as a Novel Sarco(endo)plasmic Reticulum Ca2+-ATPase 1 (SERCA1) Regulatory Protein in Skeletal Muscle*

  2015cites this paper
• Protective effect of resveratrol against pressure overload-induced heart failure

  2014cites this paper
• Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium.

  2014cites this paper
• Heme oxygenase-1 overexpression exacerbates heart failure with aging and pressure overload but is protective against isoproterenol-induced cardiomyopathy in mice.

  2014cites this paper
• Resveratrol Attenuates the Development of Trans-Aortic Constriction (TAC) Induced Heart Failure in Mice

  2013influential citation
• Discovery and Structural Characterization of a Phospholamban‐Binding Cyclic Peptide and Design of Novel Inhibitors of Phospholamban

  2013cites this paper
• Identification of novel drug targets for the treatment of heart failure

  2012cites this paper
• Resveratrol in cardiovascular disease: what is known from current research?

  2012cites this paper
• Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome

  2012cites this paper
• SERCA2a superinhibition by human phospholamban triggers electrical and structural remodeling in mouse hearts.

  2011cites this paper
• Mutations in the human phospholamban gene in patients with heart failure.

  2011cites this paper
• K201 (JTV-519) alters the spatiotemporal properties of diastolic Ca2+ release and the associated diastolic contraction during β-adrenergic stimulation in rat ventricular cardiomyocytes

  2011cites this paper
• Ca 2+ -ATPases

  2011cites this paper
• Solid-state (2)H and (15)N NMR studies of side-chain and backbone dynamics of phospholamban in lipid bilayers: investigation of the N27A mutation.

  2010cites this paper
• Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine models.

  2009cites this paper
• Factors controlling the activity of the SERCA2a pump in the normal and failing heart

  2009cites this paper
• Moderate intensity of regular exercise improves cardiac SR Ca2+ uptake activity in ovariectomized rats.

  2009cites this paper
• Structural and Dynamic Basis of Phospholamban and Sarcolipin Inhibition of Ca2+-ATPase†

  2008cites this paper
• The role of SERCA2a/PLN complex, Ca2+ homeostasis, and anti-apoptotic proteins in determining cell fate

  2008cites this paper
• Structural and dynamic basis of phospholamban and sarcolipin inhibition of Ca(2+)-ATPase.

  2008cites this paper
• The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy

  2008cites this paper
• Structural and Dynamic Basis of Phospholamban and Sarcolipin Inhibition of

  2008cites this paper
• Gender differences in the modulation of cardiac gene expression by dietary conjugated linoleic acid isomers.

  2007cites this paper
• Cardiac overexpression of antioxidant catalase attenuates aging-induced cardiomyocyte relaxation dysfunction.

  2007cites this paper
• New perspectives on the role of SERCA2's Ca2+ affinity in cardiac function.

  2006cites this paper
• The Presence of Lys27 Instead of Asn27 in Human Phospholamban Promotes Sarcoplasmic Reticulum Ca2+-ATPase Superinhibition and Cardiac Remodeling

  2006cites this paper
• A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy

  2006cites this paper
• Cardiac overexpression of alcohol dehydrogenase (ADH) alleviates aging‐associated cardiomyocyte contractile dysfunction: role of intracellular Ca2+ cycling proteins

  2006cites this paper
• Severe impairment of ventricular compliance accounts for advanced age-associated hemodynamic dysfunction in rats.

  2006cites this paper
• Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phospholamban in calcium pump regulation.

  2005cites this paper
• Resistance to store depletion-induced endothelial injury in rat lung after chronic heart failure.

  2005cites this paper
• Role of phospholamban in the pathogenesis of heart failure.

  2005cites this paper
• Calcium cycling proteins in heart failure, cardiomyopathy and arrhythmias

  2004cites this paper
• The Critical Role of Phospholamban in Cardiac Function

  2004cites this paper
• Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice.

  2004cites this paper
• Calcium: Phospholamban: a crucial regulator of cardiac contractility

  2003cites this paper
• Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human.

  2003cites this paper
• Targeting signaling pathways in heart failure by gene transfer

  2003cites this paper
• Calcium and the Failing Heart: Phospholamban, Good Guy or Bad Guy?

  2003cites this paper